MAP3K1 and Langerhans cell histiocytosis: In recent years, it was found that the MAPK pathway is involved in the pathogenesis of LCH, with the mutation of more than half of BRAF, 20% of MAP2K1 and rare ARAF, MAP3K1 (2, 15).